Delivery Order SPE2DB22D2103-SPE2DB25FR8VW

Award Date 2/14/25
Potential Completion Date 2/18/25
Potential Value $31K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,213.54, is for the delivery of LIVALO 1 MG TABLET 90S, a pharmaceutical product, with a completion date of February 2, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an award value of $63,593.08 and a completion date of December 27, 2024. It is a delivery order contract with a firm fixed-price pricing type. The contract provides for the delivery of LIVALO 1 MG TABLET 90S, a pharmaceutical product, to support military and federal healthcare programs. Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,631.76, is for the delivery of 4566914864 - LIVALO 1 MG TABLET 90S. The contract is a Firm Fixed Price Delivery Order with a completion date of January 14, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, with ID SPE2DX15D1053|SPE2DX24F6MBP, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,806.70 firm fixed-price delivery order is for the supply of LIVALO 1 MG TABLET 90S, with a period of performance through May 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,146.26, is for the delivery of LIVALO 2 MG TABLET 90S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of November 15, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $8,508.93, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of LIVALO 2 MG TABLET 90S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,711.72, is a delivery order for the supply of LIVALO 4 MG TABLET 90S, a prescription medication. The contract has an ultimate completion date of October 31, 2024 and is a firm fixed-price contract. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,680.12, is a Firm Fixed Price Delivery Order for the supply of LIVALO 4 MG TABLET 90S, a prescription medication. The contract has an ultimate completion date of May 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop...
This federal contract award, valued at $1,159.66, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract provides for the delivery of LIVALO 2 MG TABLET 90S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of May 31, 2024 and is a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This federal contract award, with ID SPE2DX15D2213|SPE2DX24F7X5T, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,416.12 firm fixed-price delivery order is for the supply of LIVALO 4 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of November 3, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite...
  • SPE2DB22D2103
    Indefinite Delivery Contract
  • SPE2DB22D2103-SPE2DB25FR8VW
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,173.70, is a Firm Fixed Price Delivery Order for 4567280072 LIVALO 2 MG TABLET 90S. The contract has an ultimate completion date of February 18, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

This contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen, as the prime contractor, is responsible for delivering the requested pharmaceutical products to support the medical needs of the military and other federal beneficiaries.

Generated 5/16/25, 11:45 AM